脓毒症患者高动力型左心室收缩功能的发生率与预后:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Cochrane Central Register of Controlled Trials和Embase,纳入4项研究,评估成人脓毒症患者高动力型左心室收缩功能(以LVEF 70%为 cutoff 定义)的发生率及其与短期死亡率的关系。汇总发生率为18.2%(95%CI 12.5, 25.8;I²=7.0%,P<0.0001)。高动力型左心室收缩功能与更高的死亡率相关(OR 2.37,95%CI 1.47, 3.80;I²=79%,P<0.01)。与正常左心室收缩功能相比,E/e'无差异(P=0.43),高动力型患者心率更高(均数差6.14次/min,95%CI 3.59, 8.69;I²=51%,P<0.0001),LVEDD更小(均数差-0.21 cm,95%CI -0.33, -0.09;I²=73%,P<0.001)。
要点
- 脓毒症患者高动力型左心室收缩功能(LVEF 70%为界)汇总发生率为18.2%(95%CI 12.5, 25.8;I²=7.0%,P<0.0001)。
- 高动力型左心室收缩功能与短期死亡率升高相关:OR 2.37(95%CI 1.47, 3.80;I²=79%,P<0.01)。
- 高动力型患者心率更高:均数差6.14次/min(95%CI 3.59, 8.69;I²=51%,P<0.0001)。
- 高动力型患者LVEDD更小:均数差-0.21 cm(95%CI -0.33, -0.09;I²=73%,P<0.001)。
- E/e'在正常与高动力型左心室收缩功能之间无差异(P=0.43)。
适用人群与场景
- 成人脓毒症患者
诊断标准与关键阈值
- 高动力型左心室收缩功能定义为左心室射血分数(LVEF)70%为 cutoff。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,纳入4项研究。
- 主要结局:高动力型左心室收缩功能汇总发生率为18.2%(95%CI 12.5, 25.8;I²=7.0%,P<0.0001)。
- 高动力型左心室收缩功能与更高死亡率相关:OR 2.37(95%CI 1.47, 3.80;I²=79%,P<0.01)。
- 次要结局:E/e'在正常与高动力型左心室收缩功能之间无差异(P=0.43)。
- 高动力型患者心率更高:均数差6.14次/min(95%CI 3.59, 8.69;I²=51%,P<0.0001)。
- 高动力型患者LVEDD更小:均数差-0.21 cm(95%CI -0.33, -0.09;I²=73%,P<0.001)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症患者高动力型左心室收缩功能的发生率不可忽视,且该发现与较正常左心室收缩功能显著更高的短期死亡率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The prevalence of hyperdynamic left ventricular (LV) systolic function in septic patients and its impact on mortality remain controversial. In this systematic review and meta-analysis, we investigated the prevalence and association of hyperdynamic LV systolic function with mortality in patients with sepsis.
METHODS: We searched MEDLINE, Cochrane Central Register of Controlled Trials, and Embase. Primary outcomes were the prevalence of hyperdynamic LV systolic function in adult septic patients and the associated short-term mortality as compared to normal LV systolic function. Hyperdynamic LV systolic function was defined using LV ejection fraction (LVEF) of 70% as cutoff. Secondary outcomes were heart rate, LV end-diastolic diameter (LVEDD), and E/e' ratio.
RESULTS: Four studies were included, and the pooled prevalence of hyperdynamic LV systolic function was 18.2% ([95% confidence interval (CI) 12.5, 25.8]; I2 = 7.0%, P < 0.0001). Hyperdynamic LV systolic function was associated with higher mortality: odds ratio of 2.37 [95%CI 1.47, 3.80]; I2 = 79%, P < 0.01. No difference was found in E/e' (P = 0.43) between normal and hyperdynamic LV systolic function, while higher values of heart rate (mean difference: 6.14 beats/min [95%CI 3.59, 8.69]; I2 = 51%, P < 0.0001) and LVEDD (mean difference: - 0.21 cm [95%CI - 0.33, - 0.09]; I2 = 73%, P < 0.001) were detected in patients with hyperdynamic LV systolic function.
CONCLUSION: The prevalence of hyperdynamic LV systolic function is not negligible in septic patients. Such a finding is associated with significantly higher short-term mortality as compared to normal LV systolic function.
参考来源
- Sato R, Sanfilippo F, Hasegawa D, et al. Prevalence and prognosis of hyperdynamic left ventricular systolic function in septic patients: a systematic review and meta-analysis. Ann Intensive Care. 2024. PMID: 38308701. doi:10.1186/s13613-024-01255-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。